Riggs Josh 4
4 · Oncocyte Corp · Filed May 22, 2024
Insider Transaction Report
Form 4
Riggs Josh
CEO and President
Transactions
- Award
Option to Purchase Common Stock
2024-05-20+90,000→ 90,000 totalExercise: $2.76Exp: 2034-05-20→ Common Stock (90,000 underlying)
Footnotes (1)
- [F1]25% of the options will vest and thereby be exercisable after one year of continuous service from the effective date of grant, and the balance will vest and thereby be exercisable in 36 equal monthly installments commencing one year after the date of grant, subject to continuous service through the applicable vesting date.